Alnylam Pharma (ALNY) Tops Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $251.65 --0%
EPS Growth %: -39.0%
Financial Fact:
Net loss: -90.13M
Today's EPS Names:
NEOV, MANU, CTAS, More
EPS Growth %: -39.0%
Financial Fact:
Net loss: -90.13M
Today's EPS Names:
NEOV, MANU, CTAS, More
Join SI Premium – FREE
Alnylam Pharma (NASDAQ: ALNY) reported Q1 EPS of ($0.62), $0.04 better than the analyst estimate of ($0.66). Revenue for the quarter came in at $18.51 million versus the consensus estimate of $15.4 million.
For earnings history and earnings-related data on Alnylam Pharma (ALNY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- Aytu BioScience (AYTU) Tops Q4 EPS by 28c
- Nike (NKE) PT Raised to $55 at BTIG
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
